By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Procyon BioPharma Inc. 

1650 Trans-Canada, Suite 200

Montreal  Quebec  H9P1H7  Canada
Phone: 514-685-9283 Fax: 514-685-5138


SEARCH JOBS


Industry
Biotechnology






Company News
Procyon BioPharma Inc. (PBP.TO) Announces Completion Of The Acquisition Of Cellpep S.A. And The Concurrent Private Placement 3/2/2006 11:43:17 AM
Procyon BioPharma Inc. (PBP.TO) Shareholders Approve Merger Via Acquisition With Cellpep S.A. 2/24/2006 12:07:55 PM
Procyon BioPharma Inc. (PBP.TO) To Webcast Special Meeting Of Shareholders To Approve Merger Via Acquisition With Cellpep And $18.1 Million Financing 2/16/2006 12:17:45 PM
Procyon BioPharma Inc. (PBP.TO) And Cellpep To Merge Via Acquisition Creating A New Global Biopharmaceutical Company, Ambrilia Biopharma Inc. 1/19/2006 12:33:06 PM
Procyon BioPharma Inc. (PBP.TO) To Receive $1 Million In Contribution From NRC-IRAP For Its HIV/AIDS Study 1/13/2006 11:17:28 AM
Procyon BioPharma Inc. (PBP.TO) Receives Regulatory Approval To Commence Phase 1 Clinical Trial For Its Lead HIV Protease Inhibitor, PPL-100 12/8/2005 10:07:32 AM
Procyon BioPharma Inc. (PBP.TO) To Host Conference Call And Webcast To Explain PSP94 Diagnostic Marker Study Findings 12/5/2005 11:16:04 AM
Study Shows Procyon BioPharma Inc. (PBP.TO)'s PSP94 Diagnostic Marker Is Better At Detecting Aggressive Prostate Cancer - Toronto Study To Be Published In Prestigious Journal Of Urology 12/2/2005 11:08:04 AM
Procyon BioPharma Inc. (PBP.TO) To Host Conference Call And Webcast Today To Explain New Data For PPL-100 11/16/2005 2:10:09 PM
Procyon BioPharma Inc. (PBP.TO) Reports New Data For Its Lead HIV Protease Inhibitor, PPL-100, Showing A Potentially High Genetic Barrier Against The HIV Virus 11/16/2005 10:48:03 AM
1234567
//-->